Market

UKTI signs MoU with ABLE

Read more

Competition intensifies as pharma companies race to launch type II diabetes drugs

Read more

FIS and IMCD in distribution partnership

Read more

Avesthagen signs license agreement with AvestaDHATM

Read more

Novo Nordisk launches basal insulin for adult patients with type I and type II diabetes

Read more

US FDA accepts Boehringer Ingelheim’s supplemental new drug application

Read more

Bilcare starts field validation studies of its nonClonableID technology

Read more

Zandu Ayurveda launches its first clinic at Nature Cure & Yoga Centre in Kolkata

Read more

Lupin receives US FDA approval for generic rifadin capsules

Read more

DRL launches divalproex sodium extended – release tablets, USP

Read more